BJL
ANAC

Brighton Jones LLC’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Brighton Jones LLC’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,299
Closed -$300K – 205
2014
Q4 		$300K Sell
9,299
-4,226
-31% -$127K 0.07% 146
2014
Q3 		$331K Sell
13,525
-7,808
-37% -$159K 0.07% 139
2014
Q2 		$378K Buy
+21,333
New +$343K 0.09% 121

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Brighton Jones LLC's ANAC Position: Q1 2015 in Review

Brighton Jones LLC sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 9,299 shares — an estimated $300K sold.

Brighton Jones LLC first reported a position in ANAC in Q2 2014 and held it in 3 quarters. The position peaked at $378K in Q2 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • Brighton Jones LLC reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • Brighton Jones LLC sold 9,299 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $300K.
  • Brighton Jones LLC first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 3 quarters.
  • Brighton Jones LLC's ANACOR PHARMACEUTICALS INC COM position peaked at $378K in Q2 2014.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Brighton Jones LLC's 13F filing for Q1 2015, filed 4 May 2015.